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Abstract
Background: There is increasing evidence that folate, an important component of one-carbon metabolism,
modulates the epigenome. Alcohol, which can disrupt folate absorption, is also known to affect the epigenome. We
investigated the association of dietary folate and alcohol intake on leukocyte DNA methylation levels in the European
Prospective Investigation into Cancer and Nutrition (EPIC) study. Leukocyte genome-wide DNA methylation profiles on
approximately 450,000 CpG sites were acquired with Illumina HumanMethylation 450K BeadChip measured among 450
women control participants of a case-control study on breast cancer nested within the EPIC cohort. After data
preprocessing using surrogate variable analysis to reduce systematic variation, associations of DNA methylation
with dietary folate and alcohol intake, assessed with dietary questionnaires, were investigated using CpG site-
specific linear models. Specific regions of the methylome were explored using differentially methylated region
(DMR) analysis and fused lasso (FL) regressions. The DMR analysis combined results from the feature-specific
analysis for a specific chromosome and using distances between features as weights whereas FL regression
combined two penalties to encourage sparsity of single features and the difference between two consecutive
features.
Results: After correction for multiple testing, intake of dietary folate was not associated with methylation level at any
DNA methylation site, while weak associations were observed between alcohol intake and methylation level at CpG
sites cg03199996 and cg07382687, with qval = 0.029 and qval = 0.048, respectively. Interestingly, the DMR analysis
revealed a total of 24 and 90 regions associated with dietary folate and alcohol, respectively. For alcohol intake, 6
of the 15 most significant DMRs were identified through FL.
Conclusions: Alcohol intake was associated with methylation levels at two CpG sites. Evidence from DMR and FL
analyses indicated that dietary folate and alcohol intake may be associated with genomic regions with tumor
suppressor activity such as the GSDMD and HOXA5 genes. These results were in line with the hypothesis that
epigenetic mechanisms play a role in the association between folate and alcohol, although further studies are
warranted to clarify the importance of these mechanisms in cancer.
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Introduction
DNA methylation is a crucial epigenetic mechanism in-
volved in regulating important cellular processes, includ-
ing gene expression, cell differentiation, genomic
imprinting, and preservation of chromosome stability.
DNA methylation refers to the addition of methyl
groups (–CH3) to the carbon-5 position of cytosine resi-
dues in a cytosine-guanine DNA sequence (CpG) by
DNA methyltransferases. DNA methylation changes can
be influenced by many factors including aging [17, 19]
and environmental exposure such as smoking [1, 24] or
specific dietary factors [35]. Experimental evidence sug-
gests a link between B vitamins, including folate (vitamin
B9), and epigenetic modifications [3]. B vitamins, espe-
cially folate, are essential components of one-carbon
metabolism (OCM), the network of interrelated bio-
chemical reaction in which a one-carbon unit is received
from methyl donor nutrients and transferred into bio-
chemical and molecular pathways essential for DNA
replication and repair. Modifications in OCM can sig-
nificantly impact gene expression and thereby cellular
function [53].
Absorbed folate, circulating in the bloodstream, enters
the OCM cycle in the liver where it is metabolized to
5-methyltetrahydrofolate (5-methylTHF) and converted
into S-adenosylmethionine (SAM) after several successive
transformation steps (Fig. 1). SAM is the methyl donor for
numerous methylation reactions including the methyla-
tion of DNA, RNA, and proteins. The potential role of
specific dietary factors including micronutrients such as
folate, alcohol, and soya intake, in modifying breast cancer
risk via epigenetic mechanisms, has been proposed [54],
although evidence is still scarce and inconsistent.
Alcohol intake affects epigenetic profiles [32]. Ethanol
metabolism generates toxins that may directly lead to
OCM dysfunction by reducing folate absorption, increasing
renal excretion of folate, and inhibiting methionine syn-
thase, the key enzyme in the generation of the methyl
donor in the OCM [32, 33]. This antagonistic effect of alco-
hol on folate could plausibly increase the need of folate in-
take. Inadequate folate levels may result in abnormal DNA
synthesis due to a reduced availability of SAM [27] and dis-
rupted DNA repair and may, hence, influence cancer risk,
including breast cancer [4, 60].
The epidemiological evidence linking dietary folate, al-
cohol intake, and epigenome modifications is, however,
not well documented. Therefore, we investigated the rela-
tionships between dietary folate and alcohol intake with
leukocyte DNA methylation patterns in the controls from
the European Prospective Investigation into Cancer and
Nutrition (EPIC) study on breast cancer. We complemen-
ted standard regression analysis with techniques for the
identification of relevant methylated regions.
Methods
Study population
EPIC is a multicenter study that recruited over 521,000
participants, between 1992 and 2000 in 23 regional or
national centers in 10 European countries (Denmark,
France, Germany, Greece, Italy, The Netherlands,
Norway, Spain, Sweden, and the UK) [43]. Among the
367,903 women recruited in EPIC, and after exclusion of
19,583 participants with prevalent cancers at recruit-
ment (except non-melanoma skin cancer), first malig-
nant primary BC occurred for 10,713 women during
follow-up between 1992 and 2010. Within a nested
case-control study that included 2491 invasive BC cases
[34], a subsample of 960 women who completed dietary
and lifestyle questionnaires and provided blood samples
at recruitment (480 cases and 480 matched controls)
from Germany, Greece, Italy, The Netherlands, Spain,
and the UK was selected for the DNA methylation
Fig. 1 Diagram of the one-carbon metabolism pathway. MS methionine synthase, MTHFR methylenetetrahydrofolate reductase, THF tetrahydrofolate,
SAH S-adenosylhomocysteine, SAM S-adenosylmethionine
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analyses [2]. The present study included analysis of 450
controls only originally enrolled in this case-control
study on breast cancer (BC) nested within the EPIC
study.
Methylation acquisition
Genome-wide DNA methylation profiles in buffy coat
samples were quantified using the Illumina Infinium
HumanMethylation 450K (HM450K) BeadChip assay [5]
in 960 biospecimens from women included in the BC
nested case-control study. A total of 20 biospecimens
with replicates used to compare technical inter- and
intra-assay batch effects and then excluded from the
main analysis together with 19 matched pairs, i.e., 38
samples, where at least one of the two samples had a
low-quality bisulfite conversion efficiency (intensity sig-
nal< 4000) or did not pass all of the Illumina GenomeS-
tudio quality control steps, which were based on built-in
control probes for staining, hybridization, extension, and
specificity [23]. To prevent collider bias [11], as both al-
cohol intake and folate intake and DNA methylation
profiles are all potentially associated with causes of BC,
among the 902 remaining samples from the original
case-control study on BC nested within EPIC study, only
cancer-free women were selected for the present study.
For the 451 controls sample, probes with detection p
values higher than 0.05 were assigned “missing” value.
After the exclusion of 14,548 cross-reactive probes [10],
47,963 probes overlapping known SNPs with minor al-
lele frequency (MAF) greater than 5% in the overall
population (European ancestry) [10] and 1483
low-quality probes (i.e., missing in more than 5% of the
samples), 421,583 probes were left for the statistical ana-
lyses [2].
For each probe, β values were calculated as the ratio of
methylated intensity over the overall intensity, defined as
the sum of methylated and unmethylated intensities.
The following preliminary adjustment steps were applied
to β values: (i) color bias normalization using smooth
quantile normalization [13], (ii) quantile normalization
[6], and (iii) type I and type II bias correction using the
beta-mixture quantile normalization (BMIQ) [56]. Then,
M values, defined as Mvalues ¼ log2ð βvalues1−βvaluesÞ , were com-
puted [14]. Surrogate variable analysis (SVA) [30, 31]
was used to remove systematic variation due to the pro-
cessing of the biospecimens during methylation acquisi-
tion such as batch, indicating groups of samples
processed at the same time, and the position of the sam-
ples within the chip [40]. Then M values were standard-
ized to have an identical variance of 1.
The percentage of white blood cell counts, i.e., T cells
(CD8+T and CD4+T), natural killer (NK) cells, B cells,
monocytes, and granulocytes, was quantified using
Houseman’s estimation method [20] and included as
covariates in the analysis.
Lifestyle and dietary exposures
Data on dietary habits were collected at recruitment
through validated center- or country-specific dietary ques-
tionnaires (DQ) [43]. Northern Italy (Florence, Turin, and
Varese), UK, Germany, and The Netherlands used
self-administered extensive quantitative food-frequency
questionnaires (FFQs), whereas Southern Italy (Naples
and Ragusa), Spain, and Greece’s centers used interview
methods. Usual consumption of alcoholic beverages
(number of glasses per day or week) per type of alcoholic
beverage (wine, beer, spirits, and liquors) during the 12
months before the administration of dietary question-
naires was collected at recruitment. In addition, 24-h diet-
ary recall (R) harmonized across EPIC countries was
collected from a random sample (n = 36,900) in each cen-
ter to be used as reference measurements [50]. R measure-
ments were used to improve estimation of alcohol content
per specific alcoholic beverages using a country-specific
estimation of average of glass volume [48]. Dietary folate
intake (μg/day) was estimated using the updated EPIC
Nutrient Data Base (ENDB) [49], obtained after
harmonization from country-specific food composition ta-
bles [7]. No specific information on the use of folate sup-
plements was available.
Statistical analyses
After exclusion of one outlier value of dietary folate
(value larger than the third quartile plus 10 times the
inter-quartile range of the distribution), a total of 450
observations from controls only were retained for statis-
tical analyses.
The association between dietary folate, alcohol intake,
and methylation levels was evaluated via (i) CpG
site-specific analysis, (ii) identification of differentially
methylated regions (DMRs) [41], and (iii) fused lasso
(FL) regression [57].
CpG site-specific models
M values expressing methylation levels at each CpG
were linearly regressed on dietary folate (log-trans-
formed to reduce skewness) and alcohol intake. Models
were adjusted for recruitment center, age at recruitment
(year), menopausal status (pre- or post-menopause), and
white blood cell counts (proportions of T cells, natural
killer cells, B cells, and monocytes in blood). False dis-
covery rate (FDR) was used to control statistical tests for
multiple testing.
For the two CpG sites that were associated with alco-
hol intake, based on q values, the percentage of methyla-
tion change for 1 standard deviation (SD) increase of
alcohol intake was calculated as follows:
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Methylation values in site j were log-transformed and
regressed on alcohol intake (Ai), for each site j, and for i
= 1,… , n, as:
log Mij
  ¼ α0 j þ α1 jAi þ γ jTZi
where α1j estimate the regression coefficient, Zi is a
vector of confounding factors related to methylation
levels through a vector of regression coefficients γj. The
ratio of any two log-transformed methylation values
log(Mij1) and log(Mij0) with a difference of alcohol intake
of 1 SD ( σ^alc ) was predicted as α^1 jσ^alc . Therefore, the
average percentage of methylation change for an in-
crease of 1-SD in alcohol intake was estimated as:
Mij1
Mij0
¼ exp α^1 jσ^alc
 
−1
   100
DMR models
Differentially methylated region (DMRs) analyses were
identified with the DMRcate package [41]. The rationale
of this method is to use kernel smoothing to replace the
t test statistics at a given CpG site by a weighted average
of t test statistics across its neighboring sites on the
same chromosome. More precisely, let pc express the
number of sites located on a given chromosome c with
c ∈ {1, … , 23} (the 23rd chromosome is chromosome X).
For any site k on this chromosome, with k = 1,… , pc, the
term tk
2 indicates the square of the t test statistics ob-
tained in site-specific analyses. For each site j on
chromosome c, tj
2 is replaced by the term t^ j
2
, defined as
t^ j
2 ¼Ppck¼1 Kjktk2:
where the terms Kjk express weights, with larger values
for sites k closer to j. Let xk express the position of site k
on the chromosome, i.e., its chromosomal coordinate in
base pairs, these weights are defined using a Gaussian
kernel, as
Kjk ¼ exp
− x j−xk
 2
2 λ=Cð Þ2
 !
where parameters λ and C represent the bandwidth and
the scaling factor, respectively. Here, we used λ = 1000
and C = 2, respectively, as recommended in [41].
Under the null hypothesis of no association between
site j and alcohol (or folate), the distribution of
t^ j
2Ppc
k
K jkPn
k
K jk 2
can be approximated by a χ2 distribution [41] with
ðPpck K jkÞ
2
=
Ppc
k K jk
2 degrees of freedom [45]. Accord-
ingly, p values were obtained for each site separately in
each chromosome and q values were computed using
FDR correction on all the p values to control for mul-
tiple testing. Then, DMRs were defined as regions with
at least two significant sites separated by a maximal dis-
tance λ of 1000 base pairs. In line with [41], t statistics tk
were obtained from regression models using an empir-
ical Bayes method to shrink the CpG site variance [51],
as implemented in the limma package [52]. For each
DMR, the minimum q value, the minimum and max-
imum coefficients (in absolute value) of the sites in-
cluded in the region were presented as qDMR, βmin, DMR,
and βmax, DMR.
Fused lasso regression
Multivariate penalized regression provides an alternative
to DMRs. We implemented a fused lasso (FL) regression
[57], which is better suited than the standard lasso when
covariates (CpGs) are naturally ordered and the objective
is to identify regions on the chromosome of differentially
methylated CpG sites. FL is particularly useful when the
number of features (p) is way larger than the sample size
(n), a situation classically known as p≫ n.
FL is a multivariable regression method combining
two penalties: (i) the lasso penalty, which introduces
sparsity of the parameter vector, i.e., many elements of
the estimated vector are encouraged to be set to zero,
and (ii) the fused penalty, which encourages sparsity of
the difference between two consecutive components in
the parameter vector, thus introducing smoothness of
parameter estimates in adjacent CpG sites [57].
To mimic the DMR analysis, a FL analysis was imple-
mented where dietary folate and alcohol were, in turn,
regressed on CpG methylation levels within each
chromosome. The vector of methylation coefficient esti-
mates β^ obtained by fused lasso regression was defined
as
β ¼ arg minf
X
i
yi−
X
j
Mijβ j−γ
TZi
 2
þλ^1
Xpc
j¼1ω j β j

þ λ^2
Xpc
j¼2ν j β j−β j−1

g;
where yi indicates, in turn, alcohol and dietary folate
values for sample i = 1,… , n, Mij is the methylation
levels at CpG site j, βj is the associated regression coeffi-
cient, Zi is a vector of confounding factors, consistently
with linear regression and DMR analyses described
above, γ is the corresponding non-penalized vector of
coefficients, and ωj and νj are the weights associated
with lasso penalty and fused penalty, respectively.
Following the rationale of the adaptive lasso [61] and
the iterated lasso [8], the FL procedure was run for the
first time with weights ωj and νj set to 1, which returned
β^0 , an initial estimate of β^ . The final estimates β^ were
obtained after running a second FL procedure with
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weights defined as ω j ¼ 1
jβ^0; jjþε
and ν j ¼ 1
jβ^0; j−β^0; j−1 jþε
,
with ε = 10−4.
The FL procedure was implemented on a predefined
grid of 50 × 50 = 2500 values for the pair of parameters
(λ1, λ2). More precisely, the grid for λ1 consisted of 50
equally spaced values (on a log scale) between λ1; max1000 and
λ1, max, where λ1, max was the lowest λ1 value for which
FL returned a null β^ vector for λ2=0, a situation where
FL reduces to a standard lasso. For each value λ1on this
grid, the grid for λ2consisted of 50 equally spaced values
(on a log scale) between λ2; maxðλ1Þ1000 and λ2, max(λ1), where
λ2, max(λ1) was the lowest λ2 value for which FL returned
a vector β^ with all components equal. The optimal pair
of tuning parameters (λ1, λ2) was selected as the one
minimizing the prediction error estimated by 5-fold
cross-validation [16], whose principle can be summa-
rized as follows. The original sample is first partitioned
into 5 equally sized subsamples. One subsample is held
as the test set while the other 4 are used as a training
set, on which FL estimates are computed for the 2500
values for (λ1, λ2). The prediction error is computed on
the test set, and the process is repeated 5 times, and for
each of the 2500 values of (λ1, λ2). The prediction error
is defined as the averaged prediction error on the 5 test
sets. FL analysis was implemented using the FusedLasso
package.
Preprocessing steps and statistical analyses were car-
ried out using the R software (https://www.r-project.org/
) and the Bioconductor packages [21], including lumi,
wateRmelon, and sva [29] for the preprocessing steps.
The nominal level of statistical significance was set to
5%.
Results
Study population characteristics
Detailed characteristics of the 450 women included in
the study are shown in Table 1. The average age at blood
collection was 52 years (range 26–73). Participants had
an average body mass index (BMI) of 26 kg/m2 (range
16–43) and were mostly post-menopausal (59%),
never-smokers (56%), and moderately physically inactive
(42%). The average daily intake of dietary folate was
270 μg/day (range 91–1012), and alcohol daily intake
was 8 g/day (range 0–72). Non-alcohol consumers, de-
fined as participants consuming less than 0.1 g/day of al-
cohol at recruitment, represented 15% of the population.
Most participants were from the Italian and the German
EPIC centers (Additional file 1: Figure S1).
CpG site-specific models
After FDR correction, dietary folate intake was not sig-
nificantly associated with methylation levels at any CpG
sites (data not shown). Alcohol intake was inversely
associated with the cg07382687 CpG site (qval =
0.048) and positively associated with the cg03199996
site (qval = 0.029) (Table 2). Both sites were located in
an open sea region, i.e., a genomic region of isolated
CpGs. cg07382687 was within the body region of
gene CREB3L2, and cg03199996 was within the body
region of gene FAM65C.
DMR analysis
A total of 24 regions associated with dietary folate were
identified, which included 190 CpG sites over-repre-
sented in the TSS1500 and 1st exon regions and
under-represented in the body regions and regions out-
side any gene regions (Fig. 2a). The 15 most significant
regions are described in Table 3 and the whole list pro-
vided in Additional file 2: Table S1. Among the 24
Table 1 Characteristics of the study population (n = 450)
Mean (SD) Min-Max
Age at blood collection (years) 52 (9) 26–73
Weight (kg) 66 (11) 40–103
Height (cm) 161 (7) 143–196
BMI (kg/m2) 26 (4) 16–43
Alcohol intake (g/day) 8 (12) 0–72
Blood folate level (nmol/L) 15 (10) 1–89
Dietary folate (μg/day) 270 (106) 91–1012
Cd8t (%) 7.5 (4) 0–23
Cd4t (%) 13.5 (5) 0–34
Natural killer (%) 6.7 (5) 0–27
B cells (%) 6.1 (2) 0–17
Monocytes (%) 5.7 (3) 0–17
Granulocytes (%) 60.8 (9) 27–85
N %
Menopausal status
Pre-menopause 186 41.3
Post-menopause 264 58.7
Smoking status
Never 250 55.6
Former 93 20.7
Smoker 104 23.1
Missing 3 0.7
Physical activity index [58]
Inactive 99 22.0
Moderate inactive 187 41.5
Moderate active 75 16.7
Active 78 10.7
Missing 11 2.4
SD standard deviation, reported for continuous variables only
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DMRs, 54% showed an inverse association with dietary
folate, i.e., had a βmax, DMR < 0. The DMR most signifi-
cantly associated with dietary folate (qDMR = 1.3E
−13, βmax, DMR = 0.019) was DMR.F1 in chromosome 7,
including 49 CpG sites, related to HOXA5 and HOXA6
genes. DMR.F5 was associated with HOXA4, another
gene of the homeobox family, (qDMR = 5.8E−4, βmax,
DMR = − 0.016).
Alcohol intake was associated with methylation levels in
90 DMRs, including 550 CpG sites over-represented in
TSS200, 1st exon, and 5′ untranslated regions (5′UTR)
and under-represented in the body regions and the re-
gions outside any gene regions (Fig. 2b). The 15 most sig-
nificant DMRs are detailed in Table 4, and the full list is
described in Additional file 3: Table S2. Alcohol intake
was positively associated with methylation levels in 66% of
the 90 DMRs. The two sites associated with alcohol intake
in the CpG site-specific analyses were not included in any
DMRs. The most significant DMR associated with alcohol
consumption was DMR.A1, 9 sites within the GSDMD
gene, (qDMR = 4.7E−14, βmax, DMR = 0.020).
Methylation levels of each CpG site located in the two
most significant DMRs for folate and alcohol,
i.e.DMR.F1, DMR.F2, DMR.A1 and DMR.A2, are pre-
sented in Additional file 4: Figure S2 by tertiles of diet-
ary folate and alcohol intake, respectively. Correlation
heatmaps of CpG sites in DMR.A1, DMR.A2, DMR.F1,
and DMR.F2 are displayed in Additional file 5: Figure
S3, showing high levels of correlation among methyla-
tion levels within the DMR.F2 of dietary folate and the
DMR.A2 of alcohol. Other regions showed less correl-
ation, including the DMR.A1 of alcohol intake.
Fused lasso regression
For dietary folate, we identified 71 FL regions, 50 present-
ing a positive association and 21 an inverse association.
Table 2 CpG site-specific model results for the significant CpG sites for alcohol intake (adjusted for recruitment center, age at
recruitment, menopausal status, and level of different lymphocyte subtypes)
CpG names Alcohol intake CpG characteristics
β(1SD)
1 qval
2 % change3 Associated genes Gene region4 Island5 Chr
1 cg03199996 0.263 0.029 9.7 FAM65C Body Open sea 20
2 cg07382687 − 0.257 0.048 − 10.3 CREB3L2 Body Open sea 7
1Coefficients for 1 standard deviation alcohol intake (SD = 11.8)
2False discovery rate (FDR) adjusted p values
3Percentage of methylation change for an increase of 1 SD increase of alcohol intake
4Gene region feature category describing the CpG position, from UCSC. TSS200 200 bases upstream of the transcriptional start site (TSS); TSS1500 1500 bases
upstream of the TSS; 5′UTR within the 5′ untranslated region, between the TSS and the ATG start site; body between the ATG and stop codon irrespective of the
presence of introns, exons, TSS, or promoters; 3′UTR between the stop codon and poly A signal
5The location of the CpG relative to the CpG island. Shore 0–2 kb from island, Shelf 2–4 kb from island, N upstream (5′) of CpG island, S downstream (3′) of CpG
island, open sea isolated CpGs in the genome
Fig. 2 Repartition of gene regions (gene region feature category describing the CpG position, from UCSC. TSS200, 200 bases upstream of the
transcriptional start site (TSS); TSS1500, 1500 bases upstream of the TSS; 5′UTR, within the 5′ untranslated region, between the TSS and the ATG
start site; body, between the ATG and stop codon; irrespective of the presence of introns, exons, TSS, or promoters; 3′UTR, between the stop
codon and poly A signal) among DMRs compare to their repartition within the Illumina 450K (the repartition of CpG sites was done among the
421,583 sites included in this study). a DMRs significant for folate. b DMRs significant for alcohol. c Illumina 450K
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Three FL regions were overlapping the 15 most sig-
nificant DMRs (Table 3). Seven out of 8 sites from a
FL region within the GDF7 gene were included in the
DMR.F2 (βFL = − 0.0029). All sites from a FL region
associated with the PRSS50 gene were part of the
DMR.F4 (βFL = − 0.0069). Six out of 7 sites from the
FL region within the GPR19 gene were within the
DMR.F9 (βFL = 0.0076). None of the 68 other FL re-
gions were overlapping any folate-related DMRs.
For alcohol consumption, we identified 133 FL re-
gions, 71 regions presenting a positive association and
62 an inverse association. Twenty-one regions were in-
cluded in alcohol-related DMRs. Among them, 9 were
overlapping 6 of the 15 most significant DMRs (Table 4).
The situation where two close FL regions were part of
the same DMR was observed 3 times in the 15 most sig-
nificant alcohol-related DMRs. In particular, four and
three sites from two FL regions located in chromosome
22 were included in DMR.A11, associated with genes
SMC1B and RIBC2. All the 9 sites from a FL region were
included in DMR.A9 (βFL = − 0.474).
Graphical representations of the DMRs, the FL re-
gions, and their overlap are illustrated for each chromo-
some in Additional file 6: Figure S4 for dietary folate
and Additional file 7: Figure S5 for alcohol intake. For
dietary folate, most of FL regions were located in
chromosome 3, chromosome 22, and chromosome X. A
maximum of four DMRs located in the same chromo-
some was observed for chromosomes 2 and 3. As for al-
cohol intake, DMR and FL showed overlap mostly in
chromosomes 6 and 22, with, respectively, 4 and 3
DMRs overlapping FL regions.
Discussion
In this study of women from a large prospective cohort,
we investigated the association of dietary folate and alco-
hol intake with leukocyte DNA methylation via three
different approaches. The site-specific analysis aimed at
identifying single CpG sites independently from each
other, whereas DMR and FL analyses aimed at identify-
ing regions of CpG sites using the inter-correlation be-
tween methylation levels in close sites, thus exploiting
Table 3 The 15 most significant DMRs associated with dietary folate out of 24 significant DMRs (adjusted for recruitment center, age
at recruitment, menopausal status, and level of different lymphocyte subtypes)
DMR characteristics CpG characteristics Fused lasso
Associated genes Gene regions hg19coord Sites1 qDMR
2 βmin, DMR
3 βmax, DMR
3 Overlap4 βFL
5
F1 HOXA5,HOXA6 1stExon, 5′UTR, TSS200,
TSS1500, 3′UTR, body
chr7:27183133-27185512 49 1.3E−13 0.0002 0.019
F2 GDF7 Body chr2:20869434-20871401 8 1.4E−08 − 0.016 − 0.033 7/8 − 0.0029
F3 CYP1A1 TSS1500 chr15:75018731-75019376 13 2.4E−05 0.0004 0.014
F4 PRSS50 Body, 1stExon, 5′UTR,
TSS200, TSS1500
chr3:46759096-46759698 9 2.4E−04 − 0.002 − 0.020 4/4 − 0.0069
F5 HOXA4 1stExon, 5′UTR, TSS200,
TSS1500
chr7:27170241-27171154 14 5.8E−04 − 0.005 − 0.016
F6 SYNGAP1 Body chr6:33401192-33401542 6 1.0E−03 0.004 0.008
F7 ZNF833 TSS1500, TSS200, body chr19:11784514-11785337 13 1.1E−03 − 0.002 − 0.012
F8 LAMB2 1stExon, 5′UTR, TSS200,
TSS1500
chr3:49170496-49170849 6 3.1E−03 − 0.008 − 0.012
F9 GPR19 5′UTR, 1stExon, TSS200,
TSS1500
chr12:12848977-12849588 9 3.7E−03 0.001 0.023 6/7 0.0076
F10 MTMR15 TSS1500, TSS200, 5′UTR,
1stExon
chr15:31195612-31196075 7 4.0E−03 − 0.003 − 0.017
F11 KCNE1 5′UTR, 1stExon, TSS200,
TSS1500
chr21:35831871-35832364 8 4.2E−03 0.007 0.019
F12 TNXB Body chr6:32054659-32055474 20 7.2E−03 0.0002 − 0.013
F13 TERT Body chr5:1269992-1270152 3 7.2E−03 0.008 0.011
F14 C2orf27A 5′UTR chr2:132481613-132481826 2 1.7E−02 0.010 0.031
F15 ANKRD44 Body chr2:198029141-198029332 3 2.1E−02 − 0.005 − 0.018
1Number of sites located in DMRs significant for dietary folate
2Minimum dietary folate q values of sites located in the DMRs (FDR correction)
3Absolute minimum and maximum of dietary folate coefficient of sites located in the DMRs, for 1 standard deviation of log-transformed diet folate (SD = 0.346)
4Number of sites from the FL region overlapping the DMR/number of sites in the FL region
5Dietary folate changes for an increase of 1 standard deviation of methylation levels of sites located in the FL region
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the potential of specific regions of the epigenome to
show methylation activity related to lifestyle factors.
While site-specific analysis showed a lack of associ-
ation between dietary folate, alcohol intake, and individ-
ual CpG sites, DMR and FL analyses identified regions
of the epigenome associated with dietary folate or alco-
hol intake. These two sites are located within the body
region of the genes FAMB65C and CREB3L2. The
FAMB65C gene, also named RIPOR3, is a non-annotated
gene. The CREB3L2 gene encodes a transcriptional acti-
vator protein and plays a critical role in cartilage devel-
opment by activating the transcription of SEC23A [18].
Translocation of CREB3L2 gene, located on chromo-
some 7, and the FUS gene (fused in sarcoma) located on
the chromosome 16 has been found in some tumors, in-
cluding skin cancer and soft tissue sarcoma [37, 38].
Alcohol is known to alter DNA methylation, mostly
because it contributes to deregulation of folate absorp-
tion, which can lead to a dysfunction of OCM [27]. In
our study, alcohol intake was associated with 90 DMRs,
some of which may have a role in specific carcinogenesis
processes. For example, alcohol intake was inversely
associated with methylation levels in DMR.A64 related
to the MLH1 gene, which is frequently mutated in her-
editary nonpolyposis colon cancer (HNPCC) [39]. A
positive association between alcohol intake and methyla-
tion in the DMR.A79 was related to the TSPAN32 (tetra-
spanin 32) gene, also known as the TSSC6 gene, which
is one of the several tumor suppressor genes located at
locus 11p15.5 in the imprinted gene domain of chromo-
some 11 [28]. This locus has been associated with adre-
nocortical carcinoma, lung, ovarian, and breast cancers.
Methylations within DMR.A1 were positively associated
with alcohol intake, and the related GSDMD gene has
also been suggested to act as a tumor suppressor [44].
Alcohol intake was also positively associated with
DMR.A6 related to the gene ADAM32, which encodes a
protein involved in diverse biological processes, such as
brain development, fertilization, tumor development,
and inflammation [36].
Several genes, associated with the 24 DMRs identified
in our study for dietary folate, were possibly involved in
biological processes leading to carcinogenesis. For ex-
ample, dietary folate was positively associated with
Table 4 The 15 most significant DMRs associated with alcohol out of 90 significant DMRs (adjusted for recruitment center, age at
recruitment, menopausal status, and level of different lymphocyte subtypes)
DMRs characteristics CpG characteristics Fused lasso
Associated genes Gene regions hg19coord Sites1 qDMR
2 βmin, DMR
3 βmax, DMR
3 Overlap4 βFL
5
A1 GSDMD TSS1500, TSS200, 5′UTR,
1stExon
chr8:144635260-144636462 9 4.7E−14 0.0060 0.020
A2 chr6:31650735-31651362 21 1.8E−13 0.0049 0.018 2/2, 2/2 0.390
A3 TRIM4 Body, 1stExon, 5′UTR,
TSS200, TSS1500
chr7:99516603-99517509 14 3.0E−06 − 0.0007 0.018
A4 RGL3 Body chr19:11517079-11517436 5 3.3E−06 0.0041 0.020
A5 COL9A3 TSS1500 chr20:61446962-61447992 32 4.8E−06 − 0.0004 − 0.012 4/4 − 1.027
A6 ADAM32 TSS1500, TSS200, 1stExon,
5′UTR, Body
chr8:38964500-38965492 10 1.3E−04 0.0019 0.014
A7 C21orf56 5′UTR, 1stExon, TSS1500 chr21:47604052-47605174 8 1.5E−04 0.0191 0.032
A8 chr2:118616155-118616576 5 1.9E−04 0.0143 0.019 5/7 0.514
A9 LTB4R2, LTB4R, CIDEB Body, 1stExon, TSS1500,
5′UTR, TSS200
chr14:24780404-24780926 10 2.3E−04 − 0.0031 − 0.012 9/9 − 0.474
A10 PTDSS2 Body chr11:457256-457304 3 3.0E−04 0.0044 0.011
A11 SMC1B, RIBC2 Body, TSS1500, 1stExon,
TSS200, 5′UTR
chr22:45808669-45810043 16 3.0E−04 0.0009 0.019 4/4, 3/3 0.332
A12 chr10:72013286-72013397 2 8.4E−04 − 0.0087 − 0.014
A13 TRAF3 Body chr14:103366987-103367858 5 1.4E−03 − 0.0044 0.013
A14 C22orf27 TSS1500, TSS200, body chr22:31317764-31318546 12 1.4E−03 0.0016 0.015 4/4, 2/2 0.641
A15 S100A13, S100A1 5′UTR, 1stExon, TSS1500,
TSS200
chr1:153599479-153600156 8 3.0E−03 0.0076 0.019
1Number of sites located in DMRs significant for alcohol
2Minimum alcohol q values of sites located in the DMRs (FDR correction)
3Absolute minimum and maximum of alcohol coefficient of sites located in the DMRs, for 1 standard deviation of alcohol intake (SD = 11.8)
4Number of sites from the FL region overlapping the DMR/number of sites in the FL region, appears twice if two FL regions are included in the DMR
5Alcohol changes for an increase of 1 standard deviation of methylation levels of sites located in the FL region or average of alcohol change if two FL regions are
included in a DMR
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methylation in DMR.F16 related to the RTKN (rhotekin)
gene, which interacts with GTP-bound Rho proteins.
Rho proteins regulate many important cellular processes,
including cell growth and transformation, cytokinesis,
transcription, and smooth muscle contraction. Dysregu-
lation of the Rho signal transduction pathway has been
implicated in many forms of cancer such as bladder can-
cer, gastric cancer, and breast cancer [9, 15]. Dietary fol-
ate was also associated with methylation levels in
DMR.F1 and DMR.F5 within the HOXA4, HOXA5, and
HOXA6 genes, members of the HOX family, known to
be associated with cellular differentiation [46]. Perturbed
HOX gene expression has been implicated in multiple
cancer types [47]. In addition, HOXA5 may also regulate
gene expression and morphogenesis. Methylation of this
gene may result in the loss of its expression and, since
the encoded protein upregulates the tumor suppressor
p53, may play an important role in tumorigenesis [55].
Results from site-specific and DMR analyses were gen-
erated with different analytical strategies: methylation
levels in different sites were assumed independent in the
former, with linear regression models fitted separately in
each CpG site, while in the latter, the physical proximity
of CpGs was exploited to identify specific regions of the
epigenome with similar methylation activity, under the
assumption that neighboring CpG sites may share rele-
vant epigenetic information. FL analysis revealed some
overlaps with DMRs, particularly for alcohol intake,
where 9 FL regions were observed within the 15 most
significant DMRs. Yet, the overlap between DMR and
FL analyses is relatively low and their results deserve
cautious interpretations as they have differences in ana-
lytical strategies. Unlike DMRs, FL does not take into ac-
count the physical distance between consecutive sites,
but rather introduce smoothness of parameters esti-
mated in adjacent mutually adjusted CpG sites. Methyla-
tion levels within a chromosome were mutually adjusted
in FL regression, while in DMR analysis t test statistics
were based on independent associations of methylation
levels with folate and alcohol.
The association between folate and DNA methylation
has been investigated at different stages of human life, in
particular during fetal development and elderly, where
folate is especially needed. A meta-analysis of
mother-offspring pairs estimated the association be-
tween maternal plasma folate during pregnancy and
DNA methylation in cord blood [25]. After FDR correc-
tion, maternal plasma folate was positively associated
with methylation level at 27 CpG sites and inversely as-
sociated with methylation level at 416 CpG sites. None
of these sites was observed in any of the 24 DMRs re-
lated to dietary folate in the present study. This might
be explained by the lack of power to identify specific
sites due to the sample size: over 2000 samples were
included in Joubert’s meta-analysis against 450 in our
study. Then, different methods were used to assess folate
intake, i.e., plasma folate against dietary folate.
An intervention study was conducted to evaluate the
effects of long-term supplementation with folic acid and
vitamin B12 on white blood cell DNA methylation in eld-
erly subjects [26]. After the intervention of 2 years, 162
sites were significantly differentially methylated com-
pared to baseline, versus 6 sites only for the placebo
group. Folate and vitamin B12 were not significantly as-
sociated with methylation level in any CpG sites. Within
the same study, 173 and 425 DMRs were identified for
folate and vitamin B12, respectively. The gene HOX4,
which was inversely associated with dietary folate in our
study in DMR.F5, was the only region overlapping with
the first 10 DMRs found in the intervention study [26].
However, a higher level of folic acid was observed in the
intervention study: averages blood folate of 52 and 23
nmol/L in the intervention and placebo groups, respect-
ively, compared to an average blood folate of 15 nmol/L
in our study which might partly explain the different
findings.
Within a recent meta-analysis including 9643 partici-
pants of European ancestry, aged 42 to 76 years with 54%
women [32], 363 CpG sites were significantly associated
with alcohol consumption, with 87% of these sites show-
ing inverse associations. In our study, site cg02711608 was
part of the 363 identified sites and was also included in
DMR.A25 associated with gene SLC1A5. SLC1A5 gene en-
codes a protein which is a sodium-dependent amino acid
transporter [42]. The important difference in the number
of significant sites between the meta-analysis and the
present study might mostly be explained by the larger
study population size and the larger levels of alcohol in-
take observed in the meta-analysis [32]. Indeed, in the
meta-analysis, composed of 46% of men, the medians of
alcohol intake ranged from 0 to 14 g/day in the 10 Euro-
pean cohorts, while with a median of 3.5 g/day, alcohol in-
take was quite low in our study, which included only
women. Lastly, cohort-specific approaches were used in
the meta-analysis to remove technical variability, while the
SVA approach was used in our study, which was shown to
produce conservative findings compared to other normal-
izing techniques [40].
In our study, the sample size was relatively low (n =
450), and women only were included. With a median
value of 3.5 g/day, a 95th percentiles equal to 31 g/day,
and a percentage of non-consumers equal to 15%, alco-
hol intake displayed limited variability which potentially
constrained the power of the study. In addition, ques-
tionnaire measurements used to assess dietary folate and
alcohol intake are prone to exposure misclassification,
which likely attenuated associations between lifestyle ex-
posures and methylation levels. These elements may
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alone explain the lack of significant associations in our
study. Further studies including men and women, pos-
sibly with larger sample size, are needed to further inves-
tigate the relationship between dietary folate, alcohol
intake, and DNA methylation.
A major strength of this study was the use of ad hoc
methodology for normalization of methylation data.
Technical management of samples likely introduces sys-
tematic technical variability in methylation measure-
ments that might compromise the accuracy of the
acquisition process and, if not properly taken into ac-
count, could introduce bias in the estimation of the as-
sociation of interest. The population used in this study
included European women from the UK, Germany, Italy,
Greece, The Netherlands, and Spain, implying a diversity
of diet and lifestyle habits. Three approaches were used
to evaluate the relationship between dietary folate, alco-
hol intake, and DNA methylation. The comparison be-
tween DMR and FL analyses was particularly relevant to
identify regions of the genome associated with dietary
folate and alcohol intake.
Alcohol was classified as group 1 carcinogen in 2012
by the IARC Monograph [22] and was associated with
cancer of the upper aero-digestive tract, female breast,
liver, and colorectum. Dietary folate has been recently
inversely associated with the risk of breast cancer in
EPIC [12], although the evidence is not conclusive [59].
Among the DMRs identified in this study for dietary fol-
ate or alcohol intake, several regions were associated
with genes potentially implicated in cancer development,
such as RTKN, the HOX family of genes, and the two
tumor suppressor genes GSDMD and TSPAN32. Our
study provides some evidence that dietary folate and al-
cohol intakes may be associated with carcinogenesis
through a deregulation of epigenetic mechanisms, al-
though our findings need to be replicated in future
evaluations.
In this study, site-specific analyses served as a basis to
explore more complex evaluations. By addressing the
high dimensionality and complexity of DNA methyla-
tion, statistical techniques used in this work may prove
useful for future epigenetic studies focusing on the rela-
tionship between lifestyle exposures, DNA methylation,
and the occurrence of disease outcomes. These tools
presented may be adapted to suit specific features of
other -omics data.
Conclusion
Weak associations between alcohol intake and methyla-
tion levels at two CpG sites were observed. DMR and FL
analyses provided evidence that specific regions of CpG
sites were associated with dietary folate and alcohol in-
take, assuming that neighboring features share relevant
epigenetic information. Folate and alcohol are known
not only to be associated with breast cancer but also to
have a mutually antagonistic role in the one-carbon me-
tabolism. In some regions identified by DMRs or FL
analysis, mapped genes are known to act as tumor sup-
pressors such as the GSDMD and HOXA5 genes. These
results were in line with the hypothesis that folate- and
alcohol-deregulated epigenetic mechanisms might have a
role in the pathogenesis of cancer.
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